Keeping abreast of the most current treatments for idiopathic OAB can lead to improved outcomes and quality of life.
David O. Sussman, DO, has been ready to educate urology colleagues on the appropriate use of Botox.
A new trial has found that mirabegronreduced the frequency of incontinence episodes and number of daily urinations in adults with overactive bladder.
Complications other than urinary incontinence or erectile dysfunction occur frequently following treatment for PCa.
Dance exercises were added to a physiotherapy program to help women strengthen pelvic floor muscles.
Increasing secretion of this hormone may prevent and treat the condition.
3-month urinary, sexual function scores predict 12-month outcomes in prostate cancer survivors.
Better subjective and objective outcomes at one year found with midurethral-sling surgery than physiotherapy.
Pad tests described to date have only been evaluated in older, parous women.
New study reveals no difference in failure rates for women younger than 70 years and those aged 70 and older.
An electronic unit vibrates three times when wetness sensor threads detect urine overspills.
No significant difference in five-year outcomes found with outside-in and inside-out transobturator tension-free vaginal tape surgery.
Taiwan study finds a twofold increased risk of upper urinary tract stones in patients suffering from urinary incontinence.
Study finds a significant inverse association between weight changes and incontinence scores in normal-weight patients.
Products advertised through fax; not FDA approved.
Consumption of 234 mg/day or more was associated with a 72% increased likelihood of urinary incontinence.
The FDA has approved onabotulinumtoxinA (Botox) as a treatment for overactive bladder (OAB) in adults who are inadequately managed with anticholinergic medications.
For women with stress urinary incontinence, changes due to pre-op studies not tied to outcome